skip to main content

News Archive

Date: 10/26/2021
The research, published in Annals of Internal Medicine, suggests that a reduction in breast cancer deaths can be achieved for Black women while maintaining the same ratio of benefits to harms that occurs when white women undergo screening every other year starting at age 50.
Date: 10/22/2021
A new report finds women physicians across all races and ethnicities earn less than their male counterparts. In fact, women physicians earn between 67 cents and 77 cents on the dollar compared to white men physicians.
Date: 10/22/2021
Rogel Cancer Center researchers have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
Date: 10/20/2021
Heavy metals like lead, industrial pollution from steel mills, coal-fired power plants or oil refineries, “forever chemicals” called PFAS that do not break down in the environment.
Date: 10/16/2021
While substantial strides have been made against some types of childhood cancers, high-grade gliomas still lack effective treatments. Thirty to 60% of these pediatric brain tumors bear mutations in the gene H3F3A.
Date: 10/08/2021
Metformin, a drug commonly prescribed against diabetes, holds promise against a rare type of childhood brain tumor in laboratory studies, an international team of researchers led by the Rogel Cancer Center report in Science Translational Medicine.
Date: 10/07/2021
Women newly diagnosed with breast or ovarian cancer who are also carriers of cancer-associated mutations like BRCA1 or BRCA2 are no more likely to die of their tumors than those who don’t have the mutations, according to a new study.
Date: 10/04/2021
Cancer centers and/or health care systems that prioritize coordination and communication provide higher-quality end-of-life care for cancer patients who are eligible for both Medicare and Medicaid, University of Michigan researchers found.
Date: 09/30/2021
The Adolescent and Young Adult (AYA) Oncology program, established at C.S. Mott Children’s Hospital and the Rogel Cancer Center is feared toward those ages 13 to 39. The initiative is made up of physicians, social workers and researchers with expertise in adult, adolescent or pediatric medicine.
Date: 09/29/2021
A common mutation in gliomas sensitizes them to immunotherapy, a finding which researchers believe could have broader therapeutic implications for all glioma patients.

Pages